Articles by Charlotte Robinson
Researchers identified three immune phenotypes of checkpoint inhibitor-induced acute interstitial nephritis.
A study assessed whether the cardiovascular and renal effects of canagliflozin are dose dependent.
Research identified the optimal biomarker combination to predict interstitial fibrosis surface in IgA nephropathy.
Survival benefits of deceased-donor kidney transplantation decrease when older patients receive lower quality organs.
Long-term data demonstrated that zigakibart reduced proteinuria and stabilized kidney function of patients with IgAN.
Winners of the 2025 ERA Awards and ERA Awards for Young Investigators were recognized at the 62nd ERA Congress.
The Annual Global Summit on Kidney Disease Innovations included sessions on rare diseases, human organ alternatives, and more
In the phase 3 REGENCY trial, adding obinutuzumab to standard therapy for lupus nephritis led to better renal outcomes.
Drs. Peter Richardson and George Wan of Mallinckrodt Pharmaceuticals discussed new data on terlipressin for HRS-AKI.
Three kidney organizations will develop a consensus framework for Centers of Excellence in Glomerular Disease Care.
The American Society of Nephrology (ASN) will create a Centers of Excellence in Home Dialysis pilot program.
Chris Klug, Timothy Caulfield, Borys Todurov, and Hongkui Deng will be keynote speakers at the World Transplant Congress.
Researchers fitted a face mask with a breath sensor that may be able to detect the presence of chronic kidney disease.
NKF SCM25, osteoporosis with lupus nephritis, kidney transplant with HIV, dialytrauma, payment for phosphate binders, more.
Researchers sought to quantify the population at risk for pruritus, clinical determinants, and associated adverse outcomes.
A study assessed whether proton pump inhibitor use accelerated CKD progression and acute kidney injury risk.
Dr. Pranav Garimella, CMO of the American Kidney Fund, discussed AMKD awareness and the importance of APOL1 gene variants.
A study examined whether treatment of in-hospital BP elevations increases the risk of AKI and other adverse outcomes.
Researchers assessed the potential association between serum uric acid levels and CV events after kidney transplantation.
A study examined dosing practices and effectiveness of the urate-lowering drug allopurinol.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.